FGF19-induced Hepatocyte Proliferation Is Mediated through FGFR4 Activation

Por Wu, Xinle, Ge, Hongfei, Lemon, Bryan, Vonderfecht, Steven, Weiszmann, Jennifer, Hecht, Randy, Gupte, Jamila, Hager, Todd, Wang, Zhulun, Lindberg, Richard, Li, Yang
Publicado em 2010

Fibroblast Growth Factor 21 Reverses Hepatic Steatosis, Increases Energy Expenditure, and Improves Insulin Sensitivity in Diet-Induced Obese Mice

Por Xu, Jing, Lloyd, David J., Hale, Clarence, Stanislaus, Shanaka, Chen, Michelle, Sivits, Glenn, Vonderfecht, Steven, Hecht, Randy, Li, Yue-Sheng, Lindberg, Richard A., Chen, Jin-Long, Jung, Dae Young, Zhang, Zhiyou, Ko, Hwi Jin, Kim, Jason K., Véniant, Murielle M.
Publicado em 2009

Rationale-Based Engineering of a Potent Long-Acting FGF21 Analog for the Treatment of Type 2 Diabetes

Por Hecht, Randy, Li, Yue-Sheng, Sun, Jeonghoon, Belouski, Ed, Hall, Michael, Hager, Todd, Yie, Junming, Wang, Wei, Winters, Dwight, Smith, Stephen, Spahr, Chris, Tam, Lei-Ting, Shen, Zhongnan, Stanislaus, Shanaka, Chinookoswong, Narumol, Lau, Yvonne, Sickmier, Allen, Michaels, Mark Leo, Boone, Thomas, Véniant, Murielle M., Xu, Jing
Publicado em 2012